All questions
Indication: Ibrance (palbociclib) in HR-positive HER2-negative advanced or metastatic breast cancer
2 questions · 3 sources
Indication questions that apply to every indication of Ibrance are on Ibrance (palbociclib), all indications: Indication.
Indication
What is Ibrance approved for with an aromatase inhibitor or fulvestrant?
Note: The IBRANCE label also lists use with inavolisib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative disease, and a HER2-positive maintenance indication; this page covers the aromatase inhibitor and fulvestrant combinations.
When was Ibrance first approved?